The NIHR Bioresource

All participants in the PROTECT study will provide two DNA samples to support the research study. All of these samples will be stored and analysed anonymously at the National Institute of Health Research (NIHR) Bioresource, and participants will have the opportunity to take part in future studies through this facility.

What is the NIHR Bioresource?

The NIHR Bioresource is funded by the National Institute of Health Research, and is a partnership between six UK research centres, including King’s College London. The NIHR Bioresource aims to collect biological samples from large numbers of people across the UK to support research.

Further information is available on the NIHR Bioresource website here -

How is PROTECT working with the NIHR Bioresource?

All DNA samples from PROTECT participants will be stored at the NIHR Bioresource. This partnership will enable:
  • Participants to take part in more future studies hosted through the NIHR Bioresource, subject to ethical approval and consent
  • Our researchers to coordinate DNA samples across the NIHR Bioresource, and analyse findings quickly and efficiently

What does this mean for participants?

All participants will provide two DNA samples using a saliva sample kit which is quick and completely painless. We will provide postage for you to return your kits to the NIHR Bioresource.

In the future you may be contacted by a member of the NIHR Bioresource team to invite you to take part in additional studies (outside of the PROTECT site). The decision to take part is entirely yours and will not impact on your involvement in PROTECT.

DNA - NIHR Bioresource FAQ

Dementia Facts

  • Dementia is an umbrella term. It describes a wide set of symptoms including memory loss, mood changes, and problems with communication
  • There are currently 800,000 people with dementia in the UK
  • There will be over a million people by 2025
  • One in three people over 65 will die with dementia
  • Dementia currently costs the UK over £20 billion each year, and this will rise to £27 billion by 2018